266 related articles for article (PubMed ID: 2729314)
1. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
Cigarroa RG; Lange RA; Williams RH; Hillis LD
Am J Med; 1989 Jun; 86(6 Pt 1):649-52. PubMed ID: 2729314
[TBL] [Abstract][Full Text] [Related]
2. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
3. Coronary angiography and acute renal failure in diabetic azotemic nephropathy.
Weinrauch LA; Healy RW; Leland OS; Goldstein HH; Kassissieh SD; Libertino JA; Takacs FJ; D'Elia JA
Ann Intern Med; 1977 Jan; 86(1):56-9. PubMed ID: 835928
[TBL] [Abstract][Full Text] [Related]
4. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
Manske CL; Sprafka JM; Strony JT; Wang Y
Am J Med; 1990 Nov; 89(5):615-20. PubMed ID: 2239981
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.
Diab OA; Helmy M; Gomaa Y; El-Shalakany R
Circ Cardiovasc Interv; 2017 Jan; 10(1):e004348. PubMed ID: 28049622
[TBL] [Abstract][Full Text] [Related]
6. Low risk of contrast media-induced acute renal failure in nonazotemic type 2 diabetes mellitus.
Shieh SD; Hirsch SR; Boshell BR; Pino JA; Alexander LJ; Witten DM; Friedman EA
Kidney Int; 1982 May; 21(5):739-43. PubMed ID: 7109460
[TBL] [Abstract][Full Text] [Related]
7. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
[TBL] [Abstract][Full Text] [Related]
8. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
Shehata M; Hamza M
Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
[TBL] [Abstract][Full Text] [Related]
9. Risks for renal dysfunction with cardiac angiography.
Taliercio CP; Vlietstra RE; Fisher LD; Burnett JC
Ann Intern Med; 1986 Apr; 104(4):501-4. PubMed ID: 3954277
[TBL] [Abstract][Full Text] [Related]
10. The incidence of contrast medium induced acute tubular necrosis following arteriography.
Lang EK; Foreman J; Schlegel JU; Leslie C; List A; McCormick P
Radiology; 1981 Jan; 138(1):203-6. PubMed ID: 7455084
[TBL] [Abstract][Full Text] [Related]
11. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans.
Weisberg LS; Kurnik PB; Kurnik BR
Ren Fail; 1993; 15(1):61-8. PubMed ID: 8441838
[TBL] [Abstract][Full Text] [Related]
13. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures.
Feldkamp T; Luedemann M; Spehlmann ME; Freitag-Wolf S; Gaensbacher J; Schulte K; Bajrovic A; Hinzmann D; Hippe HJ; Kunzendorf U; Frey N; Luedde M
Clin Res Cardiol; 2018 Feb; 107(2):148-157. PubMed ID: 28939956
[TBL] [Abstract][Full Text] [Related]
14. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
Hill JA; Winniford M; Cohen MB; Van Fossen DB; Murphy MJ; Halpern EF; Ludbrook PA; Wexler L; Rudnick MR; Goldfarb S
Am J Cardiol; 1993 Oct; 72(11):770-5. PubMed ID: 8213508
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
16. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media.
Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG
AJR Am J Roentgenol; 1991 Jul; 157(1):59-65. PubMed ID: 2048540
[TBL] [Abstract][Full Text] [Related]
17. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
18. Prevention of contrast-induced nephropathy with ascorbic acid.
Zhou L; Chen H
Intern Med; 2012; 51(6):531-5. PubMed ID: 22449658
[TBL] [Abstract][Full Text] [Related]
19. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
20. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
